A number of studies have shown that the administration of leptin induces protection during sepsis syndrome and endotoxemia by reducing the immune response and other deleterious characteristics (Dong et al., 2013; Landgraf et al., 2014; Negrin et al., 2017). The gene discussed is LEP; the disease is serum lipopolysaccharide activity.